Latest filing published 02 Feb 2022 for Sierra Oncology, Inc., €4.2M.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Joshua Richardson: trading record in brief
Joshua Richardson, listed as board member, appears in our data through filings on Sierra Oncology, Inc. shares, published by SEC (Form 4). In total, 3 filings cover trades dated from 29 January 2020 to 2 February 2022.
On the market, this insider has only ever bought: 1 purchase, €4.2M in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Besides market trades, the filings include 1 share grant. In 2022 alone, the filings show 1 purchase and no sales.
On 2 February 2022 came the latest disclosure, an open-market purchase for €4.2M in Sierra Oncology, Inc. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Joshua Richardson
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 175,000 shares@ US$27.0042.4% of flowCommon StockSEC:0000899243-22-004270:0Canonical exit: 3 May 2022 (T+90)
- 487,451 shares@ US$13.2057.6% of flowCommon StockSEC:0000899243-22-003501:0
- 1,477,320 shares0Common StockSEC:0001209191-20-005794:0
3 of 3 declarations
